Albert David Inkomsten in het verleden
Verleden criteriumcontroles 2/6
Albert David is de winst gegroeid met een gemiddeld jaarlijks percentage van 29.8%, terwijl de Pharmaceuticals industrie de winst jaarlijks groeide met 13.4%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 5.3% per jaar. Het rendement op eigen vermogen van Albert David is 16.6%, en het heeft een nettomarge van 18.1%.
Belangrijke informatie
29.8%
Groei van de winst
29.8%
Groei van de winst per aandeel
| Pharmaceuticals Groei van de industrie | 17.5% |
| Inkomstengroei | 5.3% |
| Rendement op eigen vermogen | 16.6% |
| Nettomarge | 18.1% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
A Piece Of The Puzzle Missing From Albert David Limited's (NSE:ALBERTDAVD) 26% Share Price Climb
Aug 31
Albert David (NSE:ALBERTDAVD) Is Increasing Its Dividend To ₹11.50
Jul 30Albert David (NSE:ALBERTDAVD) Has Announced That It Will Be Increasing Its Dividend To ₹11.50
Jul 16We Think That There Are Issues Underlying Albert David's (NSE:ALBERTDAVD) Earnings
May 21Positive Sentiment Still Eludes Albert David Limited (NSE:ALBERTDAVD) Following 25% Share Price Slump
Mar 20The Market Lifts Albert David Limited (NSE:ALBERTDAVD) Shares 33% But It Can Do More
Jan 20Albert David (NSE:ALBERTDAVD) Will Pay A Dividend Of ₹9.00
Jul 04Albert David (NSE:ALBERTDAVD) Is Paying Out A Dividend Of ₹9.00
May 22Here's Why We Think Albert David (NSE:ALBERTDAVD) Is Well Worth Watching
Feb 14We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Albert David Limited's (NSE:ALBERTDAVD) CEO For Now
Sep 08Calculating The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)
Feb 06Do Fundamentals Have Any Role To Play In Driving Albert David Limited's (NSE:ALBERTDAVD) Stock Up Recently?
Jan 22
Why Albert David's (NSE:ALBERTDAVD) CEO Pay Matters
Jan 07Have Insiders Been Buying Albert David Limited (NSE:ALBERTDAVD) Shares?
Dec 23Here's Why Albert David's (NSE:ALBERTDAVD) Statutory Earnings Are Arguably Too Conservative
Dec 08Should You Or Shouldn't You: A Dividend Analysis on Albert David Limited (NSE:ALBERTDAVD)
Nov 23A Look At The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)
Nov 08Should Weakness in Albert David Limited's (NSE:ALBERTDAVD) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Oct 13Is Now The Time To Put Albert David (NSE:ALBERTDAVD) On Your Watchlist?
Sep 28What Does Albert David's (NSE:ALBERTDAVD) CEO Pay Reveal?
Sep 13Are Insiders Buying Albert David Limited (NSE:ALBERTDAVD) Stock?
Aug 28Should You Buy Albert David Limited (NSE:ALBERTDAVD) For Its Dividend?
Aug 10A Look At The Fair Value Of Albert David Limited (NSE:ALBERTDAVD)
Aug 10Albert David Limited (NSE:ALBERTDAVD) Might Not Be As Mispriced As It Looks
Jul 20Opbrengsten en kosten
Hoe Albert David geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 3,786 | 685 | 1,158 | 0 |
| 30 Jun 24 | 3,599 | 708 | 1,068 | 0 |
| 31 Mar 24 | 3,625 | 754 | 1,007 | 0 |
| 31 Dec 23 | 3,548 | 662 | 909 | 0 |
| 30 Sep 23 | 3,411 | 581 | 881 | 0 |
| 30 Jun 23 | 3,403 | 579 | 886 | 0 |
| 31 Mar 23 | 3,416 | 362 | 890 | 0 |
| 31 Dec 22 | 3,345 | 366 | 926 | 0 |
| 30 Sep 22 | 3,316 | 340 | 927 | 0 |
| 30 Jun 22 | 3,256 | 266 | 936 | 0 |
| 31 Mar 22 | 3,135 | 353 | 935 | 0 |
| 31 Dec 21 | 2,959 | 384 | 911 | 0 |
| 30 Sep 21 | 2,895 | 365 | 906 | 0 |
| 30 Jun 21 | 2,748 | 337 | 828 | 0 |
| 31 Mar 21 | 2,474 | 221 | 887 | 0 |
| 31 Dec 20 | 2,507 | 116 | 942 | 0 |
| 30 Sep 20 | 2,650 | 107 | 954 | 0 |
| 30 Jun 20 | 2,829 | 88 | 976 | 0 |
| 31 Mar 20 | 3,208 | 192 | 994 | 0 |
| 31 Dec 19 | 3,285 | 299 | 1,004 | 0 |
| 30 Sep 19 | 3,259 | 272 | 1,015 | 0 |
| 30 Jun 19 | 3,141 | 198 | 1,024 | 0 |
| 31 Mar 19 | 3,169 | 177 | 1,013 | 0 |
| 31 Dec 18 | 3,160 | 179 | 1,026 | 0 |
| 30 Sep 18 | 3,136 | 206 | 1,001 | 0 |
| 30 Jun 18 | 3,271 | 287 | 993 | 0 |
| 31 Mar 18 | 2,874 | 135 | 971 | 0 |
| 31 Dec 17 | 2,976 | 76 | 1,055 | 0 |
| 30 Sep 17 | 2,799 | 17 | 1,065 | 0 |
| 30 Jun 17 | 2,784 | 4 | 1,059 | 0 |
| 31 Mar 17 | 2,949 | 171 | 1,003 | 0 |
| 31 Dec 16 | 3,008 | 103 | 1,040 | 0 |
| 30 Sep 16 | 3,130 | 68 | 1,029 | 0 |
| 30 Jun 16 | 3,165 | 70 | 840 | 0 |
| 31 Mar 16 | 3,226 | 72 | 987 | 0 |
| 31 Dec 15 | 3,229 | 81 | 1,456 | 39 |
| 30 Sep 15 | 3,255 | 139 | 1,441 | 39 |
| 30 Jun 15 | 3,236 | 146 | 1,425 | 39 |
| 31 Mar 15 | 3,208 | 137 | 919 | 0 |
| 31 Dec 14 | 3,287 | 156 | 1,296 | 43 |
| 30 Sep 14 | 3,161 | 136 | 1,262 | 43 |
| 30 Jun 14 | 3,032 | 125 | 1,221 | 43 |
| 31 Mar 14 | 2,898 | 126 | 1,199 | 43 |
| 31 Dec 13 | 2,825 | 109 | 1,118 | 25 |
Kwaliteitswinsten: ALBERTDAVD heeft een hoog niveau van non-cash earnings.
Groeiende winstmarge: De huidige netto winstmarges (18.1%) ALBERTDAVD } zijn hoger dan vorig jaar (17%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van ALBERTDAVD is de afgelopen 5 jaar aanzienlijk gegroeid met 29.8% per jaar.
Versnelling van de groei: De winstgroei van ALBERTDAVD over het afgelopen jaar ( 18% ) ligt onder het 5-jarig gemiddelde ( 29.8% per jaar).
Winst versus industrie: De winstgroei ALBERTDAVD over het afgelopen jaar ( 18% ) overtrof de Pharmaceuticals -sector 19.2%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 16.6% ) van ALBERTDAVD wordt als laag beschouwd.